OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The therapeutic potential of second and third generation CB1R antagonists
Reşat Çınar, Malliga R. Iyer, George Kunos
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107477-107477
Open Access | Times Cited: 109
Reşat Çınar, Malliga R. Iyer, George Kunos
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107477-107477
Open Access | Times Cited: 109
Showing 1-25 of 109 citing articles:
Pharmacological treatment of hyperglycemia in type 2 diabetes
Simeon I. Taylor, Zhinous Shahidzadeh Yazdi, Amber L. Beitelshees
Journal of Clinical Investigation (2021) Vol. 131, Iss. 2
Open Access | Times Cited: 179
Simeon I. Taylor, Zhinous Shahidzadeh Yazdi, Amber L. Beitelshees
Journal of Clinical Investigation (2021) Vol. 131, Iss. 2
Open Access | Times Cited: 179
Mechanisms of podocyte injury and implications for diabetic nephropathy
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 115
Federica Barutta, Stefania Bellini, Gabriella Gruden
Clinical Science (2022) Vol. 136, Iss. 7, pp. 493-520
Open Access | Times Cited: 115
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Tzu-Tang Wei, Mark Chandy, Masataka Nishiga, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1676-1693.e23
Open Access | Times Cited: 82
Tzu-Tang Wei, Mark Chandy, Masataka Nishiga, et al.
Cell (2022) Vol. 185, Iss. 10, pp. 1676-1693.e23
Open Access | Times Cited: 82
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 24
Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma
Daniel J. Tschumperlin, David Lagares
Pharmacology & Therapeutics (2020) Vol. 212, pp. 107575-107575
Open Access | Times Cited: 101
Daniel J. Tschumperlin, David Lagares
Pharmacology & Therapeutics (2020) Vol. 212, pp. 107575-107575
Open Access | Times Cited: 101
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
Daniel Wolff, Vedran Radojčić, Robert Lafyatis, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 10, pp. 817-835
Open Access | Times Cited: 101
Daniel Wolff, Vedran Radojčić, Robert Lafyatis, et al.
Transplantation and Cellular Therapy (2021) Vol. 27, Iss. 10, pp. 817-835
Open Access | Times Cited: 101
Cannabinoid Receptors: An Update on Cell Signaling, Pathophysiological Roles and Therapeutic Opportunities in Neurological, Cardiovascular, and Inflammatory Diseases
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Dhanush Haspula, Michelle A. Clark
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7693-7693
Open Access | Times Cited: 100
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism
Pengyun Li, Qiaohong Lin, Shiyang Sun, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 45
Pengyun Li, Qiaohong Lin, Shiyang Sun, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 45
Cannabidiol-Derived Cannabinoids: The Unregulated Designer Drug Market Following the 2018 Farm Bill
Charles N. Zawatsky, Sara Mills‐Huffnagle, Corinne Augusto, et al.
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 10-18
Open Access | Times Cited: 10
Charles N. Zawatsky, Sara Mills‐Huffnagle, Corinne Augusto, et al.
Medical Cannabis and Cannabinoids (2024) Vol. 7, Iss. 1, pp. 10-18
Open Access | Times Cited: 10
Cannabinoid receptor 1 ligands: Biased signaling mechanisms driving functionally selective drug discovery
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Lei Tian, Taotao Qiang, Shanglong Liu, et al.
Pharmacology & Therapeutics (2025), pp. 108795-108795
Closed Access | Times Cited: 1
Hyaluronic Acid Nanoparticles as Nanomedicine for Treatment of Inflammatory Diseases
N. Vijayakameswara Rao, Jun Gi Rho, Wooram Um, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 931-931
Open Access | Times Cited: 51
N. Vijayakameswara Rao, Jun Gi Rho, Wooram Um, et al.
Pharmaceutics (2020) Vol. 12, Iss. 10, pp. 931-931
Open Access | Times Cited: 51
Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries
Pan Gao, Mengying Cao, Xueli Jiang, et al.
Circulation (2022) Vol. 147, Iss. 2, pp. 158-174
Open Access | Times Cited: 28
Pan Gao, Mengying Cao, Xueli Jiang, et al.
Circulation (2022) Vol. 147, Iss. 2, pp. 158-174
Open Access | Times Cited: 28
360-Degree Perspectives on Obesity
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 20
Magdalena Cuciureanu, Cătălin-Cezar Caratașu, Levon Gabrielian, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1119-1119
Open Access | Times Cited: 20
Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update
Gabriella Dörnyei, Zsolt Vass, C. Juhàsz, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
Gabriella Dörnyei, Zsolt Vass, C. Juhàsz, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 306-306
Open Access | Times Cited: 16
The intervention of cannabinoid receptor in chronic and acute kidney disease animal models: a systematic review and meta-analysis
Zihao Zhao, Qianqian Yan, Junwei Xie, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Zihao Zhao, Qianqian Yan, Junwei Xie, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Anti-Obesity Therapeutic Targets Studied In Silico and In Vivo: A Systematic Review
Wendjilla Fortunato de Medeiros, Ana Francisca Teixeira Gomes, Ana Aguiar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4699-4699
Open Access | Times Cited: 6
Wendjilla Fortunato de Medeiros, Ana Francisca Teixeira Gomes, Ana Aguiar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4699-4699
Open Access | Times Cited: 6
Structural and Functional Insights into Cannabinoid Receptors
Xiaoting Li, Ling Shen, Tian Hua, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 9, pp. 665-677
Closed Access | Times Cited: 49
Xiaoting Li, Ling Shen, Tian Hua, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 9, pp. 665-677
Closed Access | Times Cited: 49
Antipsychotics cardiotoxicity: What's known and what's next
Xiaoqing Li, Xinru Tang, Liliang Li
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 736-753
Open Access | Times Cited: 34
Xiaoqing Li, Xinru Tang, Liliang Li
World Journal of Psychiatry (2021) Vol. 11, Iss. 10, pp. 736-753
Open Access | Times Cited: 34
CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity
Liliang Li, Pan Gao, Xinru Tang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Liliang Li, Pan Gao, Xinru Tang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 23
Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
Yuval Cohen, Andrew Kolodziej, Marshall Morningstar
Obesity (2024) Vol. 32, Iss. 7, pp. 1235-1244
Open Access | Times Cited: 5
The relationship between cannabis and cardiovascular disease: clearing the haze
Mark Chandy, Nerea Jimenez-Tellez, Joseph C. Wu
Nature Reviews Cardiology (2025)
Closed Access
Mark Chandy, Nerea Jimenez-Tellez, Joseph C. Wu
Nature Reviews Cardiology (2025)
Closed Access
Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Siyuan Shen, Chao Wu, Zhiqian Yang, et al.
Acta Pharmacologica Sinica (2025)
Closed Access
Unlocking the Antidiabetic Potential of CBD: In Vivo Preclinical Studies
Elena Rafailovska, Elona Xhemaili, Zorica Naumovska, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 446-446
Open Access
Elena Rafailovska, Elona Xhemaili, Zorica Naumovska, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 446-446
Open Access
